Funding Received
$42 Million in 4 Rounds from 4 Investors
Most Recent Funding
$24 Million Series B on August 25, 2014
Founded:
2011
Headquarters:
Redwood City, CA
Description:
ALDEA Pharmaceuticals develops small-molecule modulators of the ALDH family for the treatment of toxic aldehyde-related diseases.
Founders:
Wenjin Yang, Che-Hong Chen, Daria Mochly-Rosen
Categories:
Biotechnology
Website:
http://www.aldeapharma.com

Detailed Description

Update

ALDEA Pharmaceuticals is developing small-molecule modulators of the aldehyde dehydrogenase enzyme (ALDH) family, to treat toxic aldehyde-related diseases. This proprietary technology represents new product opportunities to address novel targets across multiple therapeutic areas. For example, an ALDH activator compound enhances the detoxification of acetaldehyde in the alcohol metabolism pathway, to treat acute symptoms and to reduce long-term tissue damage and cancer risk.

Current Team (8)

Update

Funding Rounds (4) - $24M

Update

Board Members and Advisors (3)

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    3696 Haven Ave, Ste C

    Redwood City, CA 94063

    USA

Images (1)

Update
  • F8dtvagn9n86gobhomxs